Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 4/20 | 0.61 |
| ▸ | PKM | P14618 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | STAT6 | P42226 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.39 |
| ▸ | RELA | Q04206 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24453868 | 0.77 | CYP19A1 (0.52) | CYP19A1PKMALDH1A1MAPTMEN1 | |
| Eremanthin SCHEMBL9516039 | 0.70 | CYP19A1 (0.56) | CYP19A1PKMALDH1A1LMNATP53 | |
| Santamarin SCHEMBL2551388 | 0.68 | PKM (0.48) | CYP19A1PKMALDH1A1LMNATP53 | |
| Santamarin SCHEMBL22305508 | 0.68 | PKM (0.48) | CYP19A1PKMALDH1A1LMNATP53 | |
| Douglanin SCHEMBL30379418 | 0.68 | PKM (0.48) | CYP19A1PKMALDH1A1LMNATP53 | |
| SCHEMBL22354262 | 0.68 | PKM (0.56) | CYP19A1PKMALDH1A1LMNATP53 | |
| Cumambrin B SCHEMBL31055363 | 0.66 | CYP19A1 (0.47) | CYP19A1PKMALDH1A1LMNATP53 | |
| SCHEMBL21563384 | 0.65 | CYP19A1 (0.40) | CYP19A1PKMALDH1A1LMNATP53 | |
| SCHEMBL21563549 | 0.65 | CYP19A1 (0.42) | CYP19A1PKMALDH1A1MAPTMAPK1 | |
| SCHEMBL21563315 | 0.65 | CYP19A1 (0.42) | CYP19A1PKMALDH1A1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220160804-A1 | USE OF LAURUS NOBILIS EXTRACT FRACTIONS TO PROTECT AGAINST AIR POLLUTION RELATED DISEASES | DSM IP ASSETS B.V. (NL) | 2022-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220160804-A1 | USE OF LAURUS NOBILIS EXTRACT FRACTIONS TO PROTECT AGAINST AIR POLLUTION RELATED DISEASES | NOS2, NOS1, NOS3 | CYP19A1 738/4885PKM 2705/4885ALDH1A1 2502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.